AU2001256148A1 - Subcutaneous administration of coagulation factor vii - Google Patents

Subcutaneous administration of coagulation factor vii

Info

Publication number
AU2001256148A1
AU2001256148A1 AU2001256148A AU5614801A AU2001256148A1 AU 2001256148 A1 AU2001256148 A1 AU 2001256148A1 AU 2001256148 A AU2001256148 A AU 2001256148A AU 5614801 A AU5614801 A AU 5614801A AU 2001256148 A1 AU2001256148 A1 AU 2001256148A1
Authority
AU
Australia
Prior art keywords
factor vii
subcutaneous administration
coagulation factor
coagulation
subcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256148A
Inventor
Jens Aas Jansen
Marie Johannessen
Ole Juul Nordfang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27439808&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001256148(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2001256148A1 publication Critical patent/AU2001256148A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU2001256148A 2000-05-03 2001-05-03 Subcutaneous administration of coagulation factor vii Abandoned AU2001256148A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
DKPA200000734 2000-05-03
DKPA200000734 2000-05-03
DKPA200001361 2000-09-13
DKPA200001361 2000-09-13
DKPA200001360 2000-09-13
DKPA200001360 2000-09-13
DKPA200100477 2001-03-22
DKPA200100477 2001-03-22
PCT/DK2001/000302 WO2001082943A2 (en) 2000-05-03 2001-05-03 Subcutaneous administration of coagulation factor vii

Publications (1)

Publication Number Publication Date
AU2001256148A1 true AU2001256148A1 (en) 2001-11-12

Family

ID=27439808

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256148A Abandoned AU2001256148A1 (en) 2000-05-03 2001-05-03 Subcutaneous administration of coagulation factor vii

Country Status (5)

Country Link
EP (1) EP1280548B1 (en)
JP (1) JP5090605B2 (en)
AU (1) AU2001256148A1 (en)
ES (1) ES2449224T3 (en)
WO (1) WO2001082943A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905683B2 (en) 2000-05-03 2005-06-14 Novo Nordisk Healthcare A/G Human coagulation factor VII variants
EP2253703A1 (en) * 2000-09-13 2010-11-24 Novo Nordisk Health Care AG Human coagulation factor VII variants
CN101486761A (en) 2000-09-13 2009-07-22 诺沃挪第克健康护理股份公司 Human coagulation factor VII variants
WO2002038162A1 (en) 2000-11-09 2002-05-16 The Scripps Research Institute MODIFIED FACTOR VIIa
US7052868B2 (en) 2001-09-27 2006-05-30 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
AU2002336919A1 (en) * 2001-11-02 2003-05-12 Novo Nordisk Health Care Ag Human coagulation factor vii polypeptides
US6960657B2 (en) 2001-11-02 2005-11-01 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
EP1446147A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk Health Care AG Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
AU2002351756A1 (en) * 2001-12-21 2003-07-15 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
ATE536886T1 (en) * 2002-05-03 2011-12-15 Novo Nordisk As STABILIZED SOLID COMPOSITIONS OF MODIFIED FACTOR VII
CA2490342C (en) 2002-06-21 2015-06-16 Novo Nordisk A/S Stabilised solid compositions of factor vii polypeptides
US6911323B2 (en) 2002-09-25 2005-06-28 Novo Nordisk Healthcare A/G Human coagulation factor VII polypeptides
US7771996B2 (en) * 2003-03-20 2010-08-10 Bayer Healthcare Llc FVII or FVIIa variants
WO2004112828A1 (en) 2003-06-25 2004-12-29 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
WO2005002615A1 (en) * 2003-07-01 2005-01-13 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides
ES2574581T3 (en) * 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Aqueous liquid pharmaceutical composition of Factor VII polypeptides
CN1863908B (en) 2003-09-09 2010-08-04 诺和诺德医疗保健公司 Coagulation factor vii polypeptides
KR20060109950A (en) 2003-12-19 2006-10-23 노보 노르디스크 헬스 케어 악티엔게젤샤프트 Stabilised compositions of factor vii polypeptides
US20080305518A1 (en) 2004-05-04 2008-12-11 Novo Nordisk Healthcare A/G O-Linked Glycoforms Of Polypeptides And Method To Manufacture Them
ES2257225B1 (en) * 2006-02-17 2007-03-16 Grifols, S.A THERAPEUTIC PREPARATION OF FVIIA OF VERY HIGH PURITY AND METHOD FOR OBTAINING IT.
CN103804489A (en) 2006-12-15 2014-05-21 巴克斯特国际公司 Factor viia-(poly)sialic acid conjugate having prolonged in vivo half-life
WO2008081024A1 (en) * 2007-01-03 2008-07-10 Novo Nordisk Health Care Ag Subcutaneous administration of coagulation factor viia-related popypeptdes
EP2014299A1 (en) * 2007-07-11 2009-01-14 Novo Nordisk A/S Subcutaneous administration of coagulation factor VII
TWI465247B (en) 2008-04-11 2014-12-21 Catalyst Biosciences Inc Factor vii polypeptides that are modified and uses thereof
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
DK2459224T3 (en) 2009-07-27 2016-07-25 Baxalta GmbH Blodstørkningsproteinkonjugater
HUE028056T2 (en) 2009-07-27 2016-11-28 Baxalta GmbH Blood coagulation protein conjugates
US8809501B2 (en) 2009-07-27 2014-08-19 Baxter International Inc. Nucleophilic catalysts for oxime linkage
CN102573920B (en) 2009-07-27 2015-01-14 利普森技术有限公司 Glycopolysialylation of non-blood coagulation proteins
CA2822591C (en) 2010-12-22 2020-12-29 Baxter International Inc. Materials and methods for conjugating a water soluble fatty acid derivative to a protein
PE20150226A1 (en) 2012-04-16 2015-02-14 Cantab Biopharmaceuticals Patent Ltd OPTIMIZED THERAPEUTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION
GB201417589D0 (en) 2014-10-06 2014-11-19 Cantab Biopharmaceuticals Patents Ltd Pharmaceutical Formulations
EP3833381B1 (en) 2019-08-15 2022-08-03 Catalyst Biosciences, Inc. Modified factor vii polypeptides for subcutaneous administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788965A (en) 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
GB9122609D0 (en) 1991-10-24 1991-12-04 Brownlee George G Improvements relating to the treatment of haemophilia
IL113010A0 (en) 1994-03-31 1995-10-31 Pharmacia Ab Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
US6372716B1 (en) 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US5925738A (en) * 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
AT408613B (en) * 1998-06-17 2002-01-25 Immuno Ag PHARMACEUTICAL FACTOR VII PREPARATION

Also Published As

Publication number Publication date
WO2001082943A2 (en) 2001-11-08
JP2003531862A (en) 2003-10-28
EP1280548A2 (en) 2003-02-05
JP5090605B2 (en) 2012-12-05
WO2001082943A3 (en) 2002-02-21
EP1280548B1 (en) 2013-12-11
ES2449224T3 (en) 2014-03-18

Similar Documents

Publication Publication Date Title
AU2001256148A1 (en) Subcutaneous administration of coagulation factor vii
AU2001285054A1 (en) Subcutaneous infusion cannula
AU2001241423A1 (en) Needleless syringe
AU2001289640A1 (en) Intracardiac blood pump
AU2001241963A1 (en) Improved medical procedure
AU2002321888A1 (en) Medical needle
AUPQ867900A0 (en) Medical injector system
AU2955200A (en) Cannula
AU2002246515A1 (en) Medicated tattoos
AU2002231039A1 (en) Therapeutic stockings
AU2001274548A1 (en) Syringe
AU3052700A (en) Medico-surgical discharge cannula
AU2001243299A1 (en) Luminescent medical bandage
EP1272240B8 (en) Hypodermic syringe
AU2001243515A1 (en) Combination drug therapy
AU2001276874A1 (en) Continuous preparation of polycarbonate
AU2001286141A1 (en) Perfusion cannula
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2002240004A1 (en) Infusion cannula
AU2002213420A1 (en) Single-use syringe
AU2001247841A1 (en) Medical procedure
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU2001280079A1 (en) Method of safe infusion
AU6106801A (en) Trans-clitoral administration of therapy